Global Antifungal Drugs Market 2022-2028

According to Gen Consulting Company, the global antifungal drugs market is set to achieve an incremental growth of USD 4 billion, acelerating at a CAGR of almost 4.1% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global antifungal drugs market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the antifungal drugs industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, infection type, drug type, indication, and region. The global market for antifungal drugs can be segmented By type: prescription, OTC. Among these, the OTC segment was accounted for the highest revenue generator in 2021. Antifungal drugs market is further segmented By infection type: superficial, topical. Based on drug type, the antifungal drugs market is segmented into: echinocandins, polyenes, azoles, antimetabolites, others. The azoles segment held the largest share of the global antifungal drugs market in 2021 and is anticipated to hold its share during the forecast period. On the basis of indication, the antifungal drugs market also can be divided into: dermatophytosis, aspergillosis, candidiasis, others. In 2021, the aspergillosis segment made up the largest share of revenue generated by the antifungal drugs market. Antifungal drugs market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By type:
- prescription
- OTC

By infection type:
- superficial
- topical

By drug type:
- echinocandins
- polyenes
- azoles
- antimetabolites
- others

By indication:
- dermatophytosis
- aspergillosis
- candidiasis
- others

By region:
- North America
- Asia Pacific
- Europe
- Rest of the World (ROW)

The market research report covers the analysis of key stake holders of the global antifungal drugs market. Some of the leading players profiled in the report include Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Dr. Reddys Laboratories Ltd., Galderma S.A., Gilead Sciences Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global antifungal drugs market.
- To classify and forecast the global antifungal drugs market based on type, infection type, drug type, indication, region.
- To identify drivers and challenges for the global antifungal drugs market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global antifungal drugs market.
- To identify and analyze the profile of leading players operating in the global antifungal drugs market.

Why Choose This Report
- Gain a reliable outlook of the global antifungal drugs market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
Prescription
OTC
PART 6. MARKET BREAKDOWN BY INFECTION TYPE
Superficial
Topical
PART 7. MARKET BREAKDOWN BY DRUG TYPE
Echinocandins
Polyenes
Azoles
Antimetabolites
Others
PART 8. MARKET BREAKDOWN BY INDICATION
Dermatophytosis
Aspergillosis
Candidiasis
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Asia Pacific
Europe
Rest of the World (ROW)
PART 10. KEY COMPANIES
Astellas Pharma Inc.
Bausch Health Companies Inc.
Bayer AG
Dr. Reddys Laboratories Ltd.
Galderma S.A.
Gilead Sciences Inc.
Janssen Pharmaceuticals, Inc.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Global Coagulation Market Analysis

2022 Global Coagulation Market AnalysisLeading and Emerging Supplier Sales, Shares and Instrument Installed Base by Geographic Region This new report from provides granular data and analysis not available from

USD 4500 View Report

Global Breast Cancer Diagnostics Market

This new 7-country report from is available by country, market segment, section, individual marker, and can be customized to specific information needs and budget.This report is designed to assist

USD 5500 View Report

COVID-19 Outbreak-Global Antifungal Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athletes foot, ringworm, candidiasis (thrush), serious systemic

USD 3660 View Report

Global Antifungal Treatment Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Antifungal Treatment Report by Material, Application, and Geography

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available